BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16186865)

  • 1. [Conjunctival primary acquired melanosis].
    Krohn J; Monge OR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C; Lommatzsch PK
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary acquired melanosis with atypia treated with mitomycin C.
    Anandajeya WV; Corrêa ZM; Augsburger JJ
    Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
    Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary acquired melanosis and melanoma of the conjunctiva.
    Vereecken G; Gobert A; De Laey JJ; Hanssens M
    Bull Soc Belge Ophtalmol; 1996; 263():97-100. PubMed ID: 9396194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J; Frucht-Pery J
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary acquired melanosis of the conjunctiva.
    Lin SM; Ferrucci S
    Optometry; 2006 May; 77(5):223-8. PubMed ID: 16651212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant melanoma of the conjunctiva].
    Charbel Issa P; Meyer-ter-Vehn T; Guthoff R; Klink T; Holz FG; Löffler K
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):663-6. PubMed ID: 18642211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
    Sugiura M; Colby KA; Mihm MC; Zembowicz A
    Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
    Frucht-Pery J; Pe'er J
    Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
    Rodríguez-Ares T; Touriño R; De Rojas V; Becerra E; Capeans C
    Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M; Finger PT
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of primary acquired melanosis of the conjunctiva].
    Arocker-Mettinger E; Haddad R
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):353-5. PubMed ID: 4087784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.